Warner Todd Hudson writes about how the FDA Set To Cut Off 17,000 Women Annually From Lifesaving Drug, a decision based on cost-cutting and rationing of care.
Five Congressmen have written to the FDA asking that Avastin continue to be available,
The United States health care system is unrivaled anywhere else on the globe. Unlike other countries, where agencies like the National Institute for Clinical Excellence (NICE) [NICE is the British health care regulatory system – WTH] frequently deny patients access to treatments deemed not to be cost-effective, our system has provided patients with unparalleled access to innovative, cutting edge medical technologies that have improved the lives of millions of individuals. Perhaps most important, the decision about what course of treatment is best kept between the patient and their health care provider, not a group of bureaucrats whose mission is to contain costs. Nowhere has this been more prevalent than in the area of cancer, where the United States leads the world in survival rates because of a historical commitment to early diagnosis, introduction of innovative treatments, and strong government programs that provide coverage and access to these services. We are concerned that this decision is the beginning of eroding this successful system in a manner that will harm patients in order to save money i a health care system fraught with other inefficiencies that can be addressed without limiting patient choice.
It’s your health. You, not the government, should be making decisions with your physician, not some bureaucrat.
Unfortunately, as Warner explains,
It seems that the Avastin decision is the first major example of Obamacare rationing and cost-cutting measures all based on bean counting instead of medicine.
Go read the full article here.
UPDATE, Thursday 9 December,
Insurance Companies Stop Treatments Based on Pending FDA Rationing Decision